Търсене

HCP Privacy Notice

HCP Privacy Notice ОБЩО УВЕДОМЛЕНИЕ ЗА ЗАЩИТА НА ЛИЧНИТЕ ДАННИ НА МЕДИЦИНСКИТЕ СПЕЦИАЛИСТИ HCP Privacy Notice Learn more   Представителството на „Такеда“ ГмбХ (Takeda GmbH) в Република Българ...

www.takeda.com/bg-bg/hcp-privacy-notice/

Ако имате коментари или въпроси във връзка с обработката на Вашите данни от страна на Такеда, във връзка с настоящата методическа бележка, съдържанието на доклада за оповестяването на информация или с...

www.takeda.com/bg-bg/who-we-are/company-information/building-trust/transparency/2016/

1781-1944

Основаване-Модернизиране: 1781-1944 Learn more

www.takeda.com/bg-bg/who-we-are/company-information/history/1781-1944/

Nycomed’s novel anti-inflammatory therapy Daxas® (roflumilast) receives marketing authorisation in the European Union for patients with COPD

Nycomed’s novel anti-inflammatory therapy Daxas® (roflumilast) receives marketing authorisation in the European Union for patients with COPD Anti-inflammatory treatment aimed at patients with severe...

www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomeds-novel-anti-inflammatory-therapy-daxas-roflumilast-receives-marketing-authorisation-in-the-european-union-for-patients-with-copd/

Nycomed and Forest Laboratories receive complete FDA response letter for Roflumilast – no additional patient trials were requested

Nycomed and Forest Laboratories receive complete FDA response letter for Roflumilast – no additional patient trials were requested For further information Media: General phone: +41 44 555 1...

www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomed-and-forest-laboratories-receive-complete-fda-response-letter-for-roflumilast--no-additional-patient-trials-were-requested/

Nycomed’s novel anti-inflammatory therapy Daxas® (roflumilast) recommended for approval in the European Union for patients with COPD

Nycomed’s novel anti-inflammatory therapy Daxas® (roflumilast) recommended for approval in the European Union for patients with COPD For further information Media: General phone: +41 44 555...

www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomeds-novel-anti-inflammatory-therapy-daxas-roflumilast-recommended-for-approval-in-the-european-union-for-patients-with-copd/

Nycomed on track in 2009

Nycomed on track in 2009 Strong growth of Key Products and in most emerging markets was partly offset by the negative impact of pantoprazole's patent expiry in Europe, the economic downturn and adver...

www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomed-on-track-in-2009/

Фирмена философия

Корпоративна култура Takeda - Takeda-ism ще ни води, за да постигнем нашата визия Мисия Мисията ни е да се стремим към по-добро здраве и по-светло бъдеще за хората по света, като въвеждаме иновации ...

www.takeda.com/bg-bg/who-we-are/corporate-philosophy/

Нашите истории

Нашите истории Разберете историите на Takeda, свързани с иновациите, грижите и наследството НАУЧЕТЕ ПОВЕЧЕ Takeda - Our Stories - Find out Takeda's stories related on Innovation, Caring and Herit...

www.takeda.com/bg-bg/our-stories/

Корпоративна отговорност

CSR на Takeda CSR на Takeda Като корпоративни граждани ние мислим за това, което можем да направим за пациентите Основни политики за корпоративната социална отговорност През повече от 235 години от...

www.takeda.com/bg-bg/corporate-responsibility/

Резултати от търсенето